Insulin in the regulation of insulin-like growth factor binding protein-3 in healthy men and patients with type 1 diabetes mellitus

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 11, Issue 5, 1998, Pages 273-278

  Ebeling, P ^a,c   Koistinen, H ^a   Seppala M ^a   Koivisto, V A ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Lilly Research Laboratories   (Germany)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

IGF I hyperinsulinemia; IGFBP 3; T1DM

Indexed keywords

GROWTH HORMONE; HEMOGLOBIN A1C; INSULIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS;

EID: 0032414315     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Jones J.I., Clemmons D.R.: Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16: 3-34, 1995.
2. Baxter R.C.: Insulin-like growth factor binding proteins in the human circulation: a review. Horm. Res. 42: 140-144, 1994.
3. Bach L.A., Rechler M.M.: Insulin-like growth factor binding proteins. Diabetes Rev. 3: 38-61, 1995.
4. Blum W.F., Ranke M.B.: Insulin-like growth factor binding proteins (IGFBPs) with special reference to IGFBP-3. Acta Paediatr. Scand. (Suppl 367): 55-62, 1990.
5. Guler H.-P., Zapf J., Schmid C., Froesch E.R.: Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol. (Copenh.) 121: 753-758, 1989.
6. Buckbinder L., Talbott R., Velasco-Miguel S., Takenaka I., Faha B., Seizinger B.R., Kley N.: Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377: 646-649, 1995.
7. Baxter R.C., Martin J.L.: Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma. J. Clin. Invest. 78:1504-1512, 1986.
8. Argente J., Barrios V., Pozo J., Munoz M.T., Hervás F., Stene M., Hernández M.: Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: age and sex-related changes. J. Clin. Endocrinol. Metab. 77:1522-1528, 1993.
9. Joergensen J.O.L., Moeller N., Moeller J., Weeke J., Blum W.F.: Insulin-like growth factors (IGF)-I and -II and IGF binding protein -1, -2 and -3 in patients with acromegaly before and after adenotomy. Metabolism 43: 579-583, 1994.
10. Cohen P., Fielder P.J., Hasegawa Y., Frisch H., Giudice L.C., Rosenfeld R.G.: Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinol. (Copenh.) 124: (Suppl 2): 74-85, 1991.
11. Corpas E., Harman S.M., Blackman M.R.: Human growth hormone and human aging. Endocr. Rev. 14: 20-39, 1993.
12. Vuorinen-Markkola H., Koivisto V.A., Yki-Järvinen H.: Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type diabetic patients. Diabetes 41: 571-580, 1992.
13. Landin K., Tengborn L., Smith U.: Effects of metformin and metoprolol CR on hormones and fibrinolytic variables during a hyperinsulinemic, euglycemic clamp in man. Thromb. Haemost. 71: 783-787, 1994.
14. Kupfer S.R., Underwood L.E., Baxter R.C., Clemmons D.R.: Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J. Clin. Invest. 91: 391-396, 1993.
15. Joergensen J.O.L., Blum W.F., Horn N., Moeller N., Moeller J., Ranke M.B., Christiansen J.S.: Insulin-like growth factors (IGF) I and II and IGF binding proteins 1, 2 and 3 during low-dose growth hormone (GH) infusion and sequential euglycemic and hypoglycemic glucose clamps: studies in GH-deficient patients. Acta Endocrinol. (Copenh.) 128: 513-520, 1993.
16. Suikkari A.-M., Koivisto V.A., Rutanen E.-M., Yki-Järvinen H., Karonen S.-L., Seppälä M.: Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J. Clin. Endocrinol. Metab. 66: 266-272, 1988.
17. DeFronzo R.A., Tobin J.D., Andres R.: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237: E214-E223, 1979.
18. Ebeling P., Bourey R., Koranyi L., Tuominen J.A., Groop L.C., Henriksson J., Mueckler M., Sovijärvi A., Koivisto V.A.: Mechanism of enhanced insulin sensitivity in athletes: Increased blood flow, muscle glucose transport protein (GLUT-4) concentration and glycogen synthase activity. J. Clin. Invest. 92: 1623-1631, 1993.
19. Koistinen H., Seppälä M., Koistinen R.: Different forms of insulin-like growth factor-binding protein 3 detected in serum and seminal plasma by immunofluorometric assay with monoclonal antibodies. Clin. Chem. 40: 531-536, 1994.
20. Desbuquois B., Aurbach G.D.: Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J. Clin. Endocrinol. 33: 732-738, 1971.
21. Heding L.G.: Radioimmunological determination of human C-peptide in serum. Diabetologia 11: 541-548, 1975.
22. Laron Z., Mannheimer S.: Measurement of human growth hormone. Isr. J. Med. Sci. 2:115-119, 1966.
23. Koistinen R., Stenman U.H., Alfthan H., Seppälä M.: Time-resolved immunofluorometric assay of 34-KDa somatomedin-binding protein. Clin. Chem. 33: 1126-1128, 1987.
24. Bang P., Brismar K., Rosenfeld R.G., Hall K.: Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects. J. Clin. Endocrinol. Metab. 78: 960-967, 1994.
25. Baxter R.C., Cowell C.T.: Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma. J. Clin. Endocrinol. Metab. 65: 432-440, 1987.
26. Hoejby Rasmussen M., Frystyk J., Andersen T., Breum L., Sandahl Christiansen J., Hilsted J.: The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin and growth hormone. Metabolism 43: 315-319, 1994.
27. Blackard W.G., Nelson N.C.: Portal and peripheral vein immunoreactive insulin concentration before and after glucose infusion. Diabetes 19: 302-308, 1970.